Search research articles
Contact Us
Filters
Showing results (151-160 of 157) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 157 results.
Cancer
|
August 20, 2021
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study
James J Harding, Tsai-Sheng Yang, Yen-Yang Chen, et al.
Experimental and Therapeutic Medicine
|
April 6, 2026
A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study
Chun-Nan Yeh, Yan-Shen Shan, Ching-Yao Yang, et al.
BMC Cancer
|
July 11, 2024
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study
Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 11, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
Chao-Hua Chiu, Cheng-Ta Yang, Jin-Yuan Shih, et al.
JTO Clinical and Research Reports
|
January 29, 2025
Durvalumab, Tremelimumab, and Platinum Chemotherapy in <i>EGFR</i> Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)
Chee Khoon Lee, Bin-Chi Liao, Shalini Subramaniam, et al.
Targeted Oncology
|
January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China
Hai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
Cancers
|
April 3, 2021
High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
Cheng-Chih Tsai, Yung-Cheng Su, Oluwaseun Adebayo Bamodu, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 157) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 157 results.
Cancer
|
August 20, 2021
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study
James J Harding, Tsai-Sheng Yang, Yen-Yang Chen, et al.
Experimental and Therapeutic Medicine
|
April 6, 2026
A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study
Chun-Nan Yeh, Yan-Shen Shan, Ching-Yao Yang, et al.
BMC Cancer
|
July 11, 2024
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study
Hui-Jen Tsai, Yan-Shen Shan, Ching-Yao Yang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 11, 2015
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
Chao-Hua Chiu, Cheng-Ta Yang, Jin-Yuan Shih, et al.
JTO Clinical and Research Reports
|
January 29, 2025
Durvalumab, Tremelimumab, and Platinum Chemotherapy in <i>EGFR</i> Mutation-Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE)
Chee Khoon Lee, Bin-Chi Liao, Shalini Subramaniam, et al.
Targeted Oncology
|
January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China
Hai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
Cancers
|
April 3, 2021
High-Grade B-Cell Lymphoma (HGBL) with <i>MYC</i> and <i>BCL2</i> and/or <i>BCL6</i> Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
Cheng-Chih Tsai, Yung-Cheng Su, Oluwaseun Adebayo Bamodu, et al.
Page
of 16